Home » Topics » Regulatory

Regulatory
RSS

FDA approves line extension for etravirine

March 29, 2012

Affymax and Takeda receive first approval for Omontys

March 28, 2012

Line extension for Taxol approved in Japan

March 22, 2012

Flagyl approved for additional indication in Japan

March 22, 2012

First once-daily 24-hour LABA for COPD maintenance launched in U.S.

March 20, 2012

First oral contraceptive for heavy menstrual bleeding approved in U.S.

March 15, 2012

FDA approves first cell-based product made from allogeneic human cells and bovine collagen

March 14, 2012

FDA approves Surfaxin

March 7, 2012

First four-strain flu vaccine approved in U.S.

March 2, 2012

Esmya approved in Europe

Feb. 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...